全文获取类型
收费全文 | 2438篇 |
免费 | 272篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 78篇 |
妇产科学 | 61篇 |
基础医学 | 388篇 |
口腔科学 | 76篇 |
临床医学 | 210篇 |
内科学 | 606篇 |
皮肤病学 | 55篇 |
神经病学 | 184篇 |
特种医学 | 111篇 |
外科学 | 267篇 |
综合类 | 117篇 |
一般理论 | 21篇 |
预防医学 | 153篇 |
眼科学 | 76篇 |
药学 | 118篇 |
中国医学 | 1篇 |
肿瘤学 | 139篇 |
出版年
2023年 | 20篇 |
2022年 | 31篇 |
2021年 | 58篇 |
2020年 | 28篇 |
2019年 | 42篇 |
2018年 | 66篇 |
2017年 | 43篇 |
2016年 | 34篇 |
2015年 | 53篇 |
2014年 | 64篇 |
2013年 | 106篇 |
2012年 | 138篇 |
2011年 | 148篇 |
2010年 | 76篇 |
2009年 | 83篇 |
2008年 | 132篇 |
2007年 | 130篇 |
2006年 | 103篇 |
2005年 | 114篇 |
2004年 | 103篇 |
2003年 | 78篇 |
2002年 | 88篇 |
2001年 | 34篇 |
2000年 | 51篇 |
1999年 | 40篇 |
1998年 | 34篇 |
1997年 | 25篇 |
1996年 | 22篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 16篇 |
1992年 | 37篇 |
1991年 | 36篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 27篇 |
1987年 | 32篇 |
1986年 | 19篇 |
1985年 | 23篇 |
1984年 | 16篇 |
1983年 | 21篇 |
1981年 | 29篇 |
1979年 | 31篇 |
1978年 | 22篇 |
1976年 | 27篇 |
1975年 | 31篇 |
1974年 | 30篇 |
1973年 | 18篇 |
1967年 | 14篇 |
1966年 | 14篇 |
排序方式: 共有2718条查询结果,搜索用时 15 毫秒
991.
Tury A Mairet-Coello G DiCicco-Bloom E 《Cerebral cortex (New York, N.Y. : 1991)》2011,21(8):1840-1856
Mounting evidence indicates cyclin-dependent kinase (CDK) inhibitors (CKIs) of the Cip/Kip family, including p57(Kip2) and p27(Kip1), control not only cell cycle exit but also corticogenesis. Nevertheless, distinct activities of p57(Kip2) remain poorly defined. Using in vivo and culture approaches, we show p57(Kip2) overexpression at E14.5-15.5 elicits precursor cell cycle exit, promotes transition from proliferation to neuronal differentiation, and enhances process outgrowth, while opposite effects occur in p57(Kip2)-deficient precursors. Studies at later ages indicate p57(Kip2) overexpression also induces precocious glial differentiation, suggesting stage-dependent effects. In embryonic cortex, p57(Kip2) overexpression advances cell radial migration and alters postnatal laminar positioning. While both CKIs induce differentiation, p57(Kip2) was twice as effective as p27(Kip1) in inducing neuronal differentiation and was not permissive to astrogliogenic effects of ciliary neurotrophic factor, suggesting that the CKIs differentially modulate cell fate decisions. At molecular levels, although highly conserved N-terminal regions of both CKIs elicit cycle withdrawal and differentiation, the C-terminal region of p57(Kip2) alone inhibits in vivo migration. Furthermore, p57(Kip2) effects on neurogenesis and gliogenesis require the N-terminal cyclin/CDK binding/inhibitory domains, while previous p27(Kip1) studies report cell cycle-independent functions. These observations suggest p57(Kip2) coordinates multiple stages of corticogenesis and exhibits distinct and common activities compared with related family member p27(Kip1). 相似文献
992.
993.
Wahl P Livio F Jacobi M Gautier E Buclin T 《Archives of orthopaedic and trauma surgery》2011,131(5):657-662
Introduction
Osteoset® T is a calcium sulphate void filler containing 4% tobramycin sulphate, used to treat bone and soft tissue infections. Despite systemic exposure to the antibiotic, there are no pharmacokinetic studies in humans published so far. Based on the observations made in our patients, a model predicting tobramycin serum levels and evaluating their toxicity potential is presented.Methods
Following implantation of Osteoset® T, tobramycin serum concentrations were monitored systematically. A pharmacokinetic analysis was performed using a non-linear mixed effects model based on a one compartment model with first-degree absorption.Results
Data from 12 patients treated between October 2006 and March 2008 were analysed. Concentration profiles were consistent with the first-order slow release and single-compartment kinetics, whilst showing important variability. Predicted tobramycin serum concentrations depended clearly on both implanted drug amount and renal function.Discussion and conclusion
Despite the popularity of aminoglycosides for local antibiotic therapy, pharmacokinetic data for this indication are scarce, and not available for calcium sulphate as carrier material. Systemic exposure to tobramycin after implantation of Osteoset® T appears reassuring regarding toxicity potential, except in case of markedly impaired renal function. We recommend in adapting the dosage to the estimated creatinine clearance rather than solely to the patient’s weight.994.
de Santana Santos T Calazans AC Martins-Filho PR Silva LC de Oliveira E Silva ED Gomes AC 《Journal of the American Dental Association (1939)》2011,142(10):1154-1162
BackgroundPain, swelling and trismus are undesirable effects of extraction of impacted mandibular third molars. The authors conducted a study to evaluate the effectiveness of the muscle relaxant cyclobenzaprine when used as a supplement to cryotherapeutic, antibiotic and steroidal anti-inflammatory treatment with the aim of reducing undesirable consequences after third-molar extraction.MethodsThe authors conducted a prospective, randomized, double-masked, placebo-controlled clinical trial involving 50 participants aged 18 to 29 years randomly assigned to receive cyclobenzaprine or the placebo. The authors used a split-mouth design, so each participant acted as his or her own control. For each participant, the authors extracted one impacted mandibular third molar on each side of the mouth at different times. Participants received 10 milligrams of cyclobenzaprine or a placebo once per day the day before surgery, the day of surgery and the first day after surgery. The authors assessed the participants' postoperative pain by means of a visual analog scale at four, six, eight, 12, 24 and 48 hours. They measured the participants' swelling and maximal interincisor distance at 48 hours and seven days.ResultsThe authors assessed both sides of each participant's mouth for differences in pain, swelling and trismus. They found no statistically significant differences between sides of the mouth regarding these three variables.ConclusionsThe results of this trial indicate that the influence of cyclobenzaprine over pain, swelling and trismus does not justify prescribing additional medication for patients undergoing third-molar extraction.Clinical ImplicationsThe muscle relaxant cyclobenzaprine was ineffective in reducing pain, swelling and trismus after third-molar extraction. 相似文献
995.
996.
Sima F Axente E Ristoscu C Mihailescu IN Kononenko TV Nagovitsin IA Chudinova G Konov VI Socol M Enculescu I Sima LE Petrescu SM 《Journal of biomedical materials research. Part A》2011,96(2):384-394
The sheltered transfer and immobilization of rabbit anti-human antiserum immunoglobulin G (IgG) by matrix-assisted pulsed laser evaporation (MAPLE) are reported. The iced targets submitted to laser irradiation consisted of 0.2-2 mg/mL IgG blended or not with lipid (L-α-phosphatidylcholine dipalmitoyl) dissolved in distilled water-based saline buffer. Thin IgG coatings were obtained at room temperature onto glass, fused silica, or silicon substrates. Ten thousand subsequent laser pulses of 0.33, 0.5, or 0.67 J/cm(2) fluence were applied for the synthesis of each sample. Morphology and composition of the thin films were studied by optical, scanning, and atomic force microscopy and Fourier transformed infrared spectrometry. Optical labeling methods such as spectrofluorimetry and fluorescence microscopy were selected to verify the biosensor transduction principle because of their high sensitivity for detecting low amounts of antigen (IgG). Protein immobilization to the substrate surface was demonstrated for all obtained structures after immersion in the donkey anti-rabbit secondary antibody solution. The IgG transfer and immobilization onto substrates were improved by addition of lipid to MAPLE solutions. 相似文献
997.
Zitt E Jäger C Rosenkranz AR Eigner M Kodras K Kovarik J Graf H Pétavy F Horn S Watschinger B 《Wiener klinische Wochenschrift》2011,123(1-2):45-52
998.
999.
Gayle S. Jameson Emanuel F. Petricoin Jasgit Sachdev Lance A. Liotta David M. Loesch Stephen P. Anthony Manpreet K. Chadha Julia D. Wulfkuhle Rosa I. Gallagher Kimberley A. Reeder Mariaelena Pierobon Monica R. Fulk Nina A. Cantafio Bryant Dunetz William D. Mikrut Daniel D. Von Hoff Nicholas J. Robert 《Breast cancer research and treatment》2014,147(3):579-588
The primary objective was to determine if multi-omic molecular profiling (MMP) informed selection of approved cancer treatments could change the clinical course of disease for patients with previously treated metastatic breast cancer (MBC) (i.e., produce a growth modulation index (GMI) ≥1.3). GMI was calculated as the ratio of progression free survival on MMP-selected therapy/time to progression on last prior treatment. To meet the primary objective at least 35 % of the subjects should demonstrate a GMI ≥1.3. Secondary endpoints included determining the response rate (according to RECIST 1.1), the percent of patients with non-progression at 4 months, and overall survival in patients whose therapy is selected by molecular profiling and proteomic analysis. Eligible patients had MBC, with ≥3 prior lines of therapy. A multi-omic based approach was performed incorporating multiplexed immunohistochemistry, c-DNA microarray, and phosphoprotein pathway activation mapping by reverse phase protein array. MMP was performed on fresh core biopsies; results were generated and sent to a Treatment Selection Committee (TSC) for review and treatment selection. Three sites enrolled 28 patients, of which 25 were evaluable. The median range of prior treatment was 7 (range 3–12). The MMP analysis and treatment recommendation were delivered within a median of 15.5 days from biopsy (range 12–23). The TSC selected MMP-rationalized treatment in 100 % (25/25) of cases. None of the MMP-based therapies were the same as what the clinician would have selected if the MMP had not been performed. GMI ≥1.3 was reported in 11/25 (44 %) patients. Partial responses were noted in 5/25 (20 %), stable disease in 8/25 (32 %) and 9/25 (36 %) had no progression at 4 months. This pilot study demonstrates the feasibility of finding possible treatments for patients with previously treated MBC using a multiplexed MMP-rationalized treatment recommendation. This MMP approach merits further investigation. 相似文献
1000.
Benninger E Laschke MW Cardell M Holstein JH Lustenberger T Keel M Trentz O Menger MD Meier C 《Shock (Augusta, Ga.)》2012,38(4):420-428
ABSTRACT: The aim of this study was to evaluate microdialysis of the rectus abdominis muscle (RAM) for early detection of subclinical organ dysfunction in a porcine model of critical intra-abdominal hypertension (IAH). Microdialysis catheters for analyses of lactate, pyruvate, and glycerol levels were placed in cervical muscles (control), gastric and jejunal wall, liver, kidney, and RAM of 30 anesthetized mechanically ventilated pigs. Catheters for venous lactate and interleukin 6 samples were placed in the jugular, portal, and femoral vein. Intra-abdominal pressure (IAP) was increased to 20 mmHg (IAH20 group, n = 10) and 30 mmHg (IAH30, n = 10) for 6 h by controlled CO2 insufflation, whereas sham animals (n = 10) exhibited a physiological IAP. In contrast to 20 mmHg, an IAH of 30 mmHg induced pathophysiological alterations consistent with an abdominal compartment syndrome. Microdialysis showed significant increase in the lactate/pyruvate ratio in the RAM of the IAH20 group after 6 h. In the IAH30 group, the strongest increase in lactate/pyruvate ratio was detected in the RAM and less pronounced in the liver and gastric wall. Glycerol increased in the RAM only. After 6 h, there was a significant increase in venous interleukin 6 of the IAH30 group compared with baseline. Venous lactate was increased compared with baseline and shams in the femoral vein of the IAH30 group only. Intra-abdominal pressure-induced ischemic metabolic changes are detected more rapidly and pronounced by microdialysis of the RAM when compared with intra-abdominal organs. Thus, the RAM represents an important and easily accessible site for the early detection of subclinical organ dysfunction during critical IAH. 相似文献